Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. Many efforts have been made to stratify CRC cases, from investigating the genomic characteristics of the tumor to – more recently – considering the gut microbiome. Differences in the composition of the gut microbiome occur along...
Gianmarco Piccinno, Paolo Manghi, Luca Lazzari et al.· Scientific Reports· 0 citations
ARCAD-derived SCAs reliably reproduced control-arm OS and benchmark treatment-effect estimates from landmark RCTs in mCRC, and supports benchmarking, trial design, and exploratory analyses when conventional control arms are impractical.
M. Raeisi, T. André, Q. Shi et al.· Journal of the National Canc...· 0 citations
Findings support TO as a meaningful composite quality benchmark integrating perioperative, oncologic, and patient-reported outcomes after robotic rectal resection with primary anastomosis.
S. Guadagni, A. Comandatore, N. Furbetta et al.· Journal of Robotic Surgery· 0 citations
High baseline circulating and tumor γδ T cells and early circulating CD8⁺PD-1⁺ T Cell expansion were associated with better outcome under AtezoBev, and an early induction of T cell-associated interferon-γ signaling at 3 weeks after the first injection of AtezoBev in patients that experienced response.
I. Galy-Fauroux, A. Asif-Laidin, M. Evain et al.· Clinical Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.